Le Lézard
Classified in: Science and technology
Subject: ACC

Repurchase of Truecaller B shares in week 19, 2023


STOCKHOLM, May 15, 2023 /PRNewswire/ -- During 08 May 2023 and 12 May 2023 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 542,858 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors.

The share buybacks form part of the share buyback programme announced by Truecaller on 23 September 2022. The share buyback programme will be executed between 23 September and up until the 2023 AGM, is being carried out in accordance "Emittentregelverket".

Truecaller B shares have been repurchased as follows:

Date:

Aggregated daily volume (number of shares):

Weighted average share price per day (SEK):

Total daily transaction value (SEK):

08 May 2023

0

0

0

09 May 2023

0

0

0

10 May 2023

0

0

0

11 May 2023

0

0

0

12 May 2023

542,858

34.3620

18,653,686.60

Total accumulated over week 19/2023

542,858

34.3620

18,653,686.60

Total accumulated during the buyback program

12,109,662

33.7545

408,755,588.78

All acquisitions have been carried out on Nasdaq Stockholm by SEB on behalf of Truecaller. Following the above acquisitions, Truecaller's holding of own shares amounts to 12,109,662 B shares and 5,100,000 C-shares as of 12 May 2023. The total number of shares in Truecaller, including own shares, is 379,059,710 and the number of outstanding shares, excluding the own shares, is 361,850,048. 

A full breakdown of the transactions is attached to this announcement.

For more information, please contact:

Andreas Frid, Head of IR & Communication 
+46 705 290800
[email protected]

About Truecaller:
Truecaller (TRUE B) is the leading global platform for verifying contacts and blocking unwanted communication. We enable safe and relevant conversations between people and make it efficient for businesses to connect with consumers. Fraud and unwanted communication are endemic to digital economies, especially in emerging markets. We are on a mission to build trust in communication. Truecaller is an essential part of everyday communication for more than 350 million active users, with half a billion downloads since launch and around 50 billion unwanted calls identified and blocked in 2022. Headquartered in Stockholm, since 2009, we are a co-founder led, entrepreneurial company, with a highly experienced management team. Truecaller is listed on Nasdaq Stockholm since 8 October 2021. For more information, please visit corporate.truecaller.com

The following files are available for download:

https://mb.cision.com/Main/20429/3769338/2059169.pdf

Press release TRUE SBB week 19 2023 UK

https://mb.cision.com/Public/20429/3769338/91fd4b5bda38f6f2.pdf

TRUECALLER transaktioner v19

 

SOURCE Truecaller AB


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: